Meloxicam is a prescription anti-inflammatory drug (NSAID) whose active ingredient targets a specific enzyme involved in pain and inflammation. It comes in tablet and liquid forms, each containing a different set of inactive ingredients alongside the same core compound. Here’s what’s actually in it and how those ingredients work.
The Active Ingredient
Meloxicam itself is the active ingredient. It belongs to a class of NSAIDs called enolic acid derivatives, and it stands out from older anti-inflammatory drugs like ibuprofen or naproxen because of how precisely it works. Your body produces two versions of an enzyme that triggers inflammation and pain. One version handles everyday functions like protecting your stomach lining and supporting kidney health. The other ramps up specifically during injury or disease to drive inflammation.
Most common NSAIDs block both versions roughly equally, which is why they can cause stomach problems. Meloxicam preferentially blocks the inflammation-driving version while leaving the protective one more intact. This selective action is the reason it was developed and why it’s often chosen for long-term conditions like osteoarthritis and rheumatoid arthritis, where people need daily pain relief without as much stomach irritation.
Inactive Ingredients in Tablets
The tablet form of meloxicam contains several inactive ingredients, none of which have a therapeutic effect. They exist to hold the pill together, help it dissolve properly, and keep it stable on the shelf:
- Microcrystalline cellulose: a plant-based filler that gives the tablet its bulk and structure
- Lactose monohydrate: a milk-derived sugar used as a filler (worth noting if you have a severe lactose sensitivity)
- Crospovidone: helps the tablet break apart quickly once swallowed so the drug can absorb
- Povidone: a binder that holds the powder together during manufacturing
- Colloidal silicon dioxide: prevents clumping and keeps the powder flowing smoothly during production
- Magnesium stearate: a lubricant that stops the tablet from sticking to the machinery
- Sodium citrate dihydrate: a buffering agent that helps stabilize the formulation
If you have allergies to any of these compounds, particularly lactose, it’s useful to know they’re present. Generic versions may use slightly different inactive ingredients, so the specific list can vary by manufacturer.
Inactive Ingredients in the Liquid Form
The oral suspension (liquid) version, originally sold as Mobic, has a completely different set of inactive ingredients designed to make a drinkable, flavored solution. These include sorbitol, glycerol, and xylitol as sweeteners, saccharin sodium for additional sweetness, sodium benzoate as a preservative, citric acid to adjust the acidity, hydroxyethylcellulose to thicken the liquid, colloidal silicon dioxide, monobasic sodium phosphate, raspberry flavor, and purified water.
The liquid form is typically used for people who have difficulty swallowing tablets, including some older adults and children with juvenile rheumatoid arthritis. The raspberry flavoring helps mask the taste of the active drug.
How Meloxicam Moves Through Your Body
After you swallow a tablet with food, blood levels of meloxicam peak around 5 to 6 hours later. It has a long half-life of 15 to 20 hours, meaning half the drug is still circulating nearly a full day after you take it. This is why meloxicam is a once-daily medication, unlike ibuprofen, which needs to be taken every 4 to 6 hours.
The standard starting dose for both osteoarthritis and rheumatoid arthritis is 7.5 mg once daily. If that doesn’t provide enough relief, the dose can be increased to 15 mg, which is the maximum recommended daily amount regardless of the condition being treated.
Key Safety Risks
Despite its selectivity, meloxicam still carries the same serious warnings that apply to all prescription NSAIDs. The FDA requires a boxed warning (the most prominent safety alert) on its label covering two major risks.
The first is cardiovascular. All NSAIDs increase the risk of heart attack and stroke, and this risk can appear early in treatment and grow with longer use. Meloxicam is specifically not to be used around the time of coronary artery bypass surgery.
The second is gastrointestinal. NSAIDs can cause bleeding, ulcers, or perforation in the stomach or intestines. These events can happen at any point during treatment and without any warning symptoms beforehand. Older adults and anyone with a history of stomach ulcers or GI bleeding face higher risk.
While meloxicam’s COX-2 selectivity does offer some stomach protection compared to less selective NSAIDs, it does not eliminate these risks entirely. The warnings apply to all doses and all durations of treatment.